non-cystic fibrosis bronchiectasis - Search News

Order byBest matchMost fresh

News

FDA, bronchiectasis

· 3d · on MSN

First drug to treat bronchiectasis lung condition approved by FDA

The U.S. Food and Drug Administration has approved Insmed's daily bronchiectasis pill, brensocatib, which will be sold under the brand name Brinsupri.

Continue reading

FDA approves brensocatib for non-cystic fibrosis bronchiectasis

Clinical Advisor · 2d

Brinsupri Approved for Non-Cystic Fibrosis Bronchiectasis

Pharmaceutical Technology on MSN3d

Insmed wins FDA approval for future blockbuster Brinsupri

Insmed's drug Brinsupri (brensocatib) has landed a double regulatory landmark win, becoming both the first marketed ...

Stocktwits on MSN3d

HC Wainwright Doubles Price Target On Insmed After Brinsupri Approval: Retail Expects Stock To Hit $150 By End Of Week

H.C. Wainwright on Wednesday doubled its price target on Insmed (INSM) to $240 from $120 while keeping a ‘Buy’ rating on the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results